AWS and SAP Expand Collaboration to Advance Digital Sovereignty Across Europe
24.9.2025 10:00:00 EEST | Business Wire | Press release
Amazon Web Services (AWS), an Amazon.com company (NASDAQ: AMZN), and SAP SE (NYSE: SAP) today unveiled plans to make SAP Sovereign Cloud capabilities available on the AWS European Sovereign Cloud, a new, independent cloud for Europe backed by a planned €7.8 billion investment from Amazon.
The collaboration builds on the companies’ longstanding partnership and SAP’s comprehensive new approach to digital sovereignty and AI innovation. SAP Sovereign Cloud capabilities are security-hardened cloud solutions from SAP, aligned with industry standards for regulated industries and governments. The collaboration will focus on uniting these capabilities and SAP's deep enterprise expertise with AWS infrastructure and operational expertise to meet customers’ evolving digital sovereignty needs across Europe.
“We’re delighted that SAP Sovereign Cloud capabilities will be available on the AWS European Sovereign Cloud. This will give organizations more choice in how they meet their sovereignty requirements while leveraging best-in-class cloud technologies,” said David Brown, vice president of Compute and Machine Learning at AWS. “SAP and AWS share a mutual vision – we want to ensure that our customers have access to some of the most advanced sovereignty solutions available, so organizations can focus on innovation and driving tangible outcomes. We’re looking forward to our ongoing collaboration with SAP and seeing the ways that organizations across Europe will innovate with the AWS European Sovereign Cloud.”
The AWS European Sovereign Cloud, which is set to launch its first AWS Region in Brandenburg, Germany by the end of 2025, is designed to give public sector organizations and customers in highly regulated industries further choice. The offering can help these organizations meet their unique digital sovereignty needs, including data residency, operational autonomy, and resiliency requirements. SAP Sovereign Cloud capabilities are already available on AWS in Australia and New Zealand (since 2023), the UK (since 2024), Canada and India (since 2025), and the addition of SAP’s capabilities to the AWS European Sovereign Cloud is a significant milestone for customers across Europe.
SAP Sovereign Cloud empowers organizations to innovate more securely, comply with local laws, and scale on their own terms. SAP Sovereign Cloud on AWS European Sovereign Cloud solutions will initially include SAP Business Technology Platform and SAP Cloud ERP. These solutions will provide customers with a secure foundation for managing critical business processes and sensitive data, while supporting compliance with relevant regulations.
“With our expanded SAP Sovereign Cloud offerings, we’re enabling customers across all industries to harness the full power of cloud innovation and AI,” said Thomas Saueressig, Member of the Executive Board of SAP SE, Customer Services and Delivery. “By deploying the SAP Sovereign Cloud portfolio on the AWS European Sovereign Cloud, customers gain access to our comprehensive suite of sovereign cloud solutions, further strengthened by our trusted, long-standing partnership with Amazon Web Services.”
The AWS European Sovereign Cloud will be separate and independent from AWS’s existing Regions and will have no critical dependencies on non-EU infrastructure. Backed by strong technical controls, sovereign assurances, and legal protections, customers can benefit from the full capacity of AWS with the same industry-leading security, resilience, and expansive service portfolio available in existing Regions.
AWS and SAP have been innovating in the cloud together for more than 16 years. This new collaboration builds on that history to support customers’ digital sovereignty requirements and accelerate their digital transformation in Europe.
About Amazon Web Services
Since 2006, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud. AWS has been continually expanding its services to support virtually any workload, and it now has more than 240 fully featured services for compute, storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, media, and application development, deployment, and management from 120 Availability Zones within 38 geographic regions, with announced plans for 10 more Availability Zones and three more AWS Regions in Chile, the Kingdom of Saudi Arabia, and the AWS European Sovereign Cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth’s Most Customer-Centric Company, Earth’s Best Employer, and Earth’s Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.
About SAP
As a global leader in enterprise applications and business AI, SAP (NYSE: SAP) stands at the nexus of business and technology. For over 50 years, organizations have trusted SAP to bring out their best by uniting business-critical operations spanning finance, procurement, HR, supply chain, and customer experience. For more information, visit www.sap.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250924911261/en/
Contacts
Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.amazon.com%
2Fpr&esheet=54328669&newsitemid=20250924911261&lan=en-US&anchor=www.amazon.com%2
Fpr&index=8&md5=890141cbb225f6cf26581f448e3324ca
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom